|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 310.90 CHF | +0.26% |
|
+1.14% | +21.68% |
| 12-05 | ROCHE HOLDINGS AG : Gets a Buy rating from UBS | ZD |
| 12-04 | Women can self-test at home for cervical cancer virus, new guidelines say | RE |
| Capitalization | 266B 330B 284B 248B 458B 29,738B 498B 3,112B 1,202B 14,045B 1,240B 1,214B 51,355B | P/E ratio 2025 * |
18x | P/E ratio 2026 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise value | 279B 347B 298B 260B 481B 31,224B 523B 3,268B 1,262B 14,747B 1,302B 1,274B 53,920B | EV / Sales 2025 * |
4.54x | EV / Sales 2026 * | 4.34x |
| Free-Float |
87.84% | Yield 2025 * |
3.18% | Yield 2026 * | 3.24% |
Last Transcript: Roche Holding AG
| 1 day | +0.26% | ||
| 1 week | +1.14% | ||
| Current month | +1.14% | ||
| 1 month | +17.28% | ||
| 3 months | +13.38% | ||
| 6 months | +16.14% | ||
| Current year | +21.68% |
| 1 week | 303 | 319 | |
| 1 month | 264.2 | 319 | |
| Current year | 231.9 | 319 | |
| 1 year | 231.9 | 319 | |
| 3 years | 212.9 | 319 | |
| 5 years | 212.9 | 404.2 | |
| 10 years | 206.35 | 404.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 58 | 2011-06-05 |
Wafaa Mamilli
CTO | Chief Tech/Sci/R&D Officer | 58 | 2025-02-09 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 67 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 58 | 2023-03-14 |
| Director/Board Member | 72 | 2015-03-02 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.26% | +1.14% | +21.30% | +0.44% | 330B | ||
| -0.41% | -6.06% | +22.37% | +173.58% | 905B | ||
| -0.27% | -2.41% | +35.05% | +12.95% | 487B | ||
| -1.15% | -0.71% | +28.33% | +37.90% | 400B | ||
| +0.58% | -2.73% | +28.01% | +20.71% | 281B | ||
| +0.19% | +2.49% | +18.48% | +24.80% | 255B | ||
| -1.16% | -4.87% | -3.70% | -9.35% | 248B | ||
| +1.24% | -2.33% | -59.84% | -31.25% | 214B | ||
| -3.02% | -4.51% | +20.25% | +15.79% | 178B | ||
| -1.14% | -3.67% | +29.80% | +37.78% | 150B | ||
| Average | -0.30% | -2.37% | +14.01% | +28.34% | 344.69B | |
| Weighted average by Cap. | -0.13% | -2.83% | +18.15% | +55.19% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 61.58B 76.48B 65.74B 57.4B 106B 6,883B 115B 720B 278B 3,251B 287B 281B 11,886B | 63.13B 78.4B 67.39B 58.84B 109B 7,056B 118B 738B 285B 3,332B 294B 288B 12,185B |
| Net income | 13.13B 16.31B 14.02B 12.24B 22.61B 1,468B 24.59B 154B 59.31B 693B 61.21B 59.91B 2,535B | 14.55B 18.07B 15.53B 13.56B 25.04B 1,626B 27.24B 170B 65.7B 768B 67.8B 66.36B 2,808B |
| Net Debt | 13.29B 16.5B 14.19B 12.39B 22.88B 1,485B 24.89B 155B 60.02B 701B 61.94B 60.62B 2,565B | 8.15B 10.13B 8.7B 7.6B 14.04B 911B 15.27B 95.37B 36.82B 430B 38B 37.19B 1,574B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 310.90 CHF | +0.26% | 937,693 |
| 25-12-04 | 310.10 CHF | -1.18% | 1,018,755 |
| 25-12-03 | 313.80 CHF | +0.16% | 1,192,175 |
| 25-12-02 | 313.30 CHF | +1.39% | 1,052,632 |
| 25-12-01 | 309.00 CHF | +0.52% | 1,147,326 |
Delayed Quote Swiss Exchange, December 05, 2025 at 11:30 am
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ROG Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















